Tag: Clark
Latest article
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Learn This Earlier than Contemplating DIOD Maker of Eco-Pleasant Tools and Diet Public Joint...
Readers who want to buy DIOD manufacturer of environmentally friendly equipment and nutrition joint-stock company (MCX: DIOD) for its dividend...